期刊文献+

40年收治维吾尔族鼻咽癌概况分析 被引量:1

General situation of the Uygur nasopharyngeal carcinoma in the recent 40 years
下载PDF
导出
摘要 目的:了解我科(1989年肿瘤医院成立前为一附院放疗科,1989年12月后为肿瘤医院放疗科)收治的维吾尔族鼻咽癌40年来的变化情况。方法:我科1960年1月~2006年12月共收治维吾尔族鼻咽癌372例,从不同时间分布分析维吾尔族发病年龄变化,病例增长情况。并统计其职业及地理分布。结果:372例维吾尔族鼻咽癌患者年龄分布较均衡,11~60岁占88.4%,1984年以前的病例,平均发病年龄为35.4岁,1985年以后为44.2岁,随时间推移发病年龄后移8年,差异有统计学意义(P<0.05)。就诊病例数逐年递增。以10年为单位计,在不同的基础上达到1.3~2.5倍。农民占49.5%,其次为工人占12.4%。喀什地区病例最多,占32.3%,阿克苏地区占18.0%。结论:维吾尔族鼻咽癌与时间分布关系密切,发病年龄随时间后移,发病例数逐年增加。 Objective: To evaluate the situation of Uygur nasopharyngeal carcinoma in the recent 40 years. Method: 372 Uygur patients with nasopharyngeal carcinoma were treated in Affiliated Tumor Hospital of Xinjiang Medical University during the past 40 years. Population distribution, age change and patient increase were analysed with Uygur nasopharyngeal carcinoma during different times. Occupation and the geographical distribution were also' analysed. Results: 88.4% of patients were at the ages of 11-60. Average age was 35.4 years before 1984. Average age was 44.2 years after1985, respectively. The average age was prolonged 8 years from time to time. There was significant difference (P〈0.05). There was an increase in the number of patients over the 40 years. To be that the ten years as a unit, there was an increases about 1.3-2.5 times for 10 years. The farmers accounted for 49.5%, While the worker accounted for 12.4%. Patients from Kashi Prefeacture were 32. 3% at most. Patients from Aksu Prefeacture were 18.0%. Conclusion: The Uygur nasopharyngeal carcinoma related closely with different period's distribution. Age was prolonged from time to time. The patients were double with time.
出处 《新疆医科大学学报》 CAS 2008年第11期1497-1499,共3页 Journal of Xinjiang Medical University
基金 卫生厅青年基金资助(2003y06)
关键词 维吾尔族 鼻咽癌 时间分布 Uygur natinality nasopharyngeal carcinoma time distribution
  • 相关文献

参考文献7

二级参考文献58

共引文献387

同被引文献14

  • 1赵春玲,宋咏梅,樊飞跃,詹启敏.细胞周期蛋白cyclin B1与肿瘤[J].肿瘤,2007,27(4):322-326. 被引量:17
  • 2胡海一,张澍田.Cyclin D1表达与肿瘤关系的研究进展[J].临床和实验医学杂志,2007,6(7):143-145. 被引量:2
  • 3林冬梅,高黎.鼻咽癌//殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学.4版,北京:中国协和医科大学出版社,2008:458-464.
  • 4Afqir S, Ismaili N, Errihani H. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status. J Can Res Ther,2009 ,5 :3-7.
  • 5Chen QY, Wen YF, Guo L, et al. Concurrent ehemoradiotherapy vs radiotherapy alone in stage Ⅱ nasopharyngeal carcinoma:phase Ⅲ randomized trial. J Natl Cancer Inst,2011,103 : 1761-1770.
  • 6Zheng XK, Chen LH, Wang WJ, et al. Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing. Int J Radiat Oncol Biol Phys, 2010,78: 1541-1547.
  • 7Xu Y, Ching YP, Zhou ~. Multiple pathways were involved in tubeimoside-1 induced cytotoxicity of HeLa ceils. J Proteomics, 201l ,75:491-501.
  • 8Hartwell LH, Kastan MB. Cell cycle control and cancer. Science, 1994,266 : 1821-1828.
  • 9Grossi F, Spizzo R, Bordo D, et al. Prognostic stratification of stage ⅢA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data : an Alpe Adria thoracic oncology multidiseiplinary group study ( ATOM 014 ). J Thorac Onco1,2010,5 : 1354-1360.
  • 10张亚军,段诗苗,徐全敬,江浩,沈学明.晚期鼻咽癌同步放化疗与单纯放疗疗效比较[J].蚌埠医学院学报,2008,33(6):756-758. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部